This article is a correction to:
Molecular Portrait of GISTs Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel
Haoran Qian1†
Na Yan
Xiaotong Hu- 1Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
- 2Dian Diagnostics Group Co., Ltd., Hangzhou, China
- 3Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Hangzhou, China
- 4Department of Pathology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
by Qian H, Yan N, Hu X, Jiang J, Cao Z and Shen D (2022). Front. Genet. 13:864499. doi: 10.3389/fgene.2022.864499
In the original article, there was an error in affiliation 3. The corrected affiliation is “Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Hangzhou, China.”
In addition, the percentage of KIT mutations in GISTs was calculated incorrectly.
A correction has been made to Abstract, Results, sentence 2. The new sentence reads as follows:
“KIT mutations occurred most often in GISTs (94/106, 88.68%), followed by point mutations in PDGFRA.”
A correction has been made to Results, Gene Mutation Distributions and Frequencies, sentence 2. The new sentence reads as follows:
“KIT mutations occurred most often in GISTs (94 of 106 tumors, 88.68%), followed by the point mutation in PDGFRA.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: gastrointestinal stromal tumors, molecular subtypes, clinicopathological features, next-generation sequencing, target therapy
Citation: Qian H, Yan N, Hu X, Jiang J, Cao Z and Shen D (2022) Corrigendum: Molecular Portrait of GIST Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel. Front. Genet. 13:945357. doi: 10.3389/fgene.2022.945357
Received: 16 May 2022; Accepted: 01 June 2022;
Published: 28 June 2022.
Edited and reviewed by:
Michael Baudis, University of Zurich, SwitzerlandCopyright © 2022 Qian, Yan, Hu, Jiang, Cao and Shen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Dan Shen, shendan@dazd.cn
†These authors have contributed equally to this work